The FDA has issued a draft guidance to simplify the procedure of developing drugs for rare pediatric disorders.
Researchers recently examined how the shift to unit-dose packaging of buprenorphine-naloxone products may be associated with a substantial drop in reports to poison centers of unintentional pediatric exposures.
Updated guidelines from the American Academy of Pediatrics identify significantly more children with elevated blood pressure than previously reported.
An advisory panel to the FDA has unanimously voted in favor of approving the first cannabis-derived medicine in the country—a childhood epilepsy treatment.
A recent study examined how many children receive codeine after common childhood surgeries despite warnings from doctors and drug regulators about the dangers of opioids in children.
High Levels of Variability and Inconsistencies in Dosing Directions and Measuring Devices in Pediatric OTC MedicationsResults of a descriptive study of the top-selling 200 pediatric OTC medications on the market during 52 weeks found high levels of variability and inconsistency in dosing directions and measuring devices.